Solventum Corporation (SOLV) Average EV/EBITDA Ratio
The current ev/ebitda ratio for Solventum Corporation (SOLV) is 6.69x as of Friday, June 12, 2026, shown against its trailing averages.
Average EV/EBITDA Ratio Chart
SOLV EV/EBITDA Ratio Averages
EV/EBITDA RATIO CURRENT
6.69x
EV/EBITDA RATIO TTM
10.17x
EV/EBITDA RATIO 3Y
10.29x
EV/EBITDA RATIO 5Y
10.29x
EV/EBITDA RATIO 10Y
10.29x
EV/EBITDA RATIO 15Y
10.29x
EV/EBITDA RATIO 20Y
10.29x
About Solventum Corporation
Solventum Corporation, established in 2023 and headquartered in Saint Paul, Minnesota, operates as a healthcare entity dedicated to pioneering, producing, and commercializing diverse solutions that address critical needs for both customers and patients. The company's business activities are organized into four principal segments. The Medsurg division furnishes various products and services, including sophisticated wound care items, intravenous (I.V.) site management tools, sterilization assurance systems, temperature regulation devices, surgical instruments, stethoscopes, and medical electrodes. Its Dental Solutions segment provides a comprehensive range of dental and orthodontic offerings, such as brackets, clear aligners, restorative filling materials, and bonding agents. The Health Information Systems division concentrates on advanced software platforms, covering functionalities like computer-assisted physician documentation, direct billing and coding automation, classification frameworks, voice recognition capabilities, and data visualization tools. Finally, the Purification and Filtration segment supplies an array of purification and filtration technologies, including various filters, purifiers, cartridges, and specialized membranes.
- Sector
- Healthcare
- Industry
- Medical - Care Facilities
- CEO
- Bryan C. Hanson